Literature DB >> 992719

Purification of cobra venom factor from phospholipase A contaminant.

P J Lachmann, L Halbwachs, A Gewurz, H Gewurz.   

Abstract

It has been demonstrated that cobra venom factor prepared by the usual combination of ion exchange chromatography and sephadex gel filtration is contaminated by substantial amounts of a 'heavy' phospholipase A. The two activities may be separated by isoelectric focusing. Cobra venom factor focuses at pH between 5-75 and 6-75 whereas the phospholipase is all found at pH below 7-75. In certain test systems, particularly in vitro, and particularly where albumin concentrations are low, the contaminating phospholipase may produce effects that have been attributed to complement activation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 992719      PMCID: PMC1445186     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Reaction mechanism of the alternative pathway of complement fixation.

Authors:  P J Lachmann; P Nicol
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

3.  Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.

Authors:  R J Pickering; M R Wolfson; R A Good; H Gewurz
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

4.  Isoelectric focusing of proteins in the native and denatured states. Anomalous behaviour of plasma albumin.

Authors:  M R Salaman; A R Williamson
Journal:  Biochem J       Date:  1971-03       Impact factor: 3.857

5.  Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.

Authors:  H J Müller-Eberhard; K E Fjellström
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

6.  Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes.

Authors:  H S Shin; H Gewurz; R Snyderman
Journal:  Proc Soc Exp Biol Med       Date:  1969-05

7.  Complement-unlike hemolytic activity in lobster hemolymph.

Authors:  J L Hall; D T Rowlands; U R Nilsson
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

8.  The failure to show a necessary role for C3 in the in vitro antibody response.

Authors:  H Waldmann; P J Lachmann
Journal:  Eur J Immunol       Date:  1975-03       Impact factor: 5.532

9.  Formation and function of a complex of the C3 proactivator with a protein from cobra venom.

Authors:  N R Cooper
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Lysis of erythrocytes by complement in the absence of antibody.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

View more
  11 in total

1.  Role of the acute phase response in the Shwartzman phenomenon.

Authors:  M B Pepys; S L Rogers; D J Evans
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

2.  Lymphocyte traffic through antigen-stimulated lymph nodes. I. Complement activation within lymph nodes initiates cell shutdown.

Authors:  I McConnell; J Hopkins
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

3.  Effect of complement depletion by cobra venom factor on fowlpox virus infection in chickens and chicken embryos.

Authors:  H Ohta; Y Yoshikawa; C Kai; K Yamanouchi; H Taniguchi; K Komine; Y Ishijima; H Okada
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

4.  Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.

Authors:  H Ohta; Y Yoshikawa; C Kai; K Yamanouchi; H Okada
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

5.  Phospholipase A2 contamination of cobra venom factor preparations. Biologic role in complement-dependent in vivo reactions and inactivation with p-bromophenacyl bromide.

Authors:  J O Shaw; M F Roberts; R J Ulevitch; P Henson; E A Dennis
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

6.  Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo.

Authors:  Xinhua Zhang; Yuko Kimura; Chongyun Fang; Lin Zhou; Georgia Sfyroera; John D Lambris; Rick A Wetsel; Takashi Miwa; Wen-Chao Song
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

7.  Delayed hypersensitivity reactions to Listeria monocytogenes in rats decomplemented with cobra factor and in C5-deficient mice.

Authors:  T W Jungi; M B Pepys
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

8.  Studies in the rat of antibody-coated and N-ethylmaleimide-treated erythrocyte clearance by the spleen. I. Effects of in vivo complement activation.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

9.  Acute joint inflammation in mice after systemic injection of the cell wall, its peptidoglycan, and chemically defined peptidoglycan subunits from various bacteria.

Authors:  T Koga; K Kakimoto; T Hirofuji; S Kotani; H Ohkuni; K Watanabe; N Okada; H Okada; A Sumiyoshi; K Saisho
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

10.  In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats.

Authors:  S Matsuo; S Ichida; H Takizawa; N Okada; L Baranyi; A Iguchi; B P Morgan; H Okada
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.